Crystal structure of the human glucose transporter GLUT1
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The glucose transporter GLUT1 catalyses facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs. Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer. Despite decades of investigation, the structure of GLUT1 remains unknown. Here we report the crystal structure of human GLUT1 at 3.2 Å resolution. The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation. This structure allows accurate mapping and potential mechanistic interpretation of disease-associated mutations in GLUT1. Structure-based analysis of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily. Structural comparison of the uniporter GLUT1 with its bacterial homologue XylE, a proton-coupled xylose symporter, allows examination of the transport mechanisms of both passive facilitators and active transporters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Briefly, the U-shaped intracellular helical bundle of GLUT1 is formed by three helixes and functions as a latch to secure GLUT1 in the outward open conformation making the sugar binding site accessible extracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“GLUT1 has a single binding site that can be accessed by glucose (and other hexoses) from either side of the luminal and/or abluminal endothelial membrane extracellularly or intracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“GLUT1 is expressed in endothelial cells, but not in neurons (141, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“After binding to the extracellular binding site, glucose enters GLUT1, which leads to a conformational change causing extracellular transmembrane domains 1, 4, and 7 to function as a latch to secure the inward open conformation of GLUT1 enabling release of glucose intracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“Since glucose concentration is lower in the brain interstitial fluid (ISF) compared with plasma, GLUT1 favors blood-to-brain transport of circulating glucose (141, 390, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,046
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
Sequence and Structure of a Human Glucose Transporter
Mueckler, M., Caruso, C., Baldwin, S. A., Panico, M., Blench, I., Morris, H. R., Allard, W. J., Lienhard, G. E., & Lodish, H. F. (1985) · Science · doi:10.1126/science.3839598 · Cited by 1,547
Simple Allosteric Model for Membrane Pumps
JARDETZKY, O. (1966) · Nature · doi:10.1038/211969a0 · Cited by 1,291
Research works printed but not linked: 1
- Mitchell, P. David Keilin’s respiratory chain concept and its chemiosmotic consequences. In Nobel Lectures, Chemistry 1971–1980 (ed. Forsén, S. ) (World Scientific Publishing Co., 1978)
Cited by
Items 701–800 of 806
Analytical Methods for the Study of Opioid Peptides
Al‐Hossaini, A. M. (2017) · KU ScholarWorks (The University of Kansas)
Structure-Function Study of Human Glucose Transporter 9 (hSLC2A9)
Long, W. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3w08wx19
Application of Red Cell Membrane in Nanobiotechnology
Kim, I., Lee, G., & Yoon, D. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84274
Langó, T. (2019) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2018.190
Computational Studies and Design of PPARγ and GLUT1 Inhibitors
Almahmoud, S. A. (2019) · DigitalCommons@UNMC
Over 60 Years of Experimental Hematology (without a License)
Lodish, H. F. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.08.005
Molecular docking studies and virtual drug screening of chemosensitizers
Bruno, A., & Costantino, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820701-7.00013-0
Wnt5a Role in Cisplatin Effect and Selectivity Augmentation in Cancer Therapy
Atta, W. O., & Azeiz, A. Z. A. (2021) · OALib · doi:10.4236/oalib.1107564
“Sugar–platinum conjugates (Figure 2) have been confirmed as enzyme activating compounds that have a major role in antibody-directed enzyme prodrug therapy approach [4] [5].”
BackgroundMike Mueckler (1953–2021): the father of the mammalian SLC2 glucose transporter family
James, D. E., & Thorens, B. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00290.2021
Felker, I., Игоревна, Г. Е., Stavitskaya, N. V., Першина, В. А., & Bаtyrshinа, Y. R. (2021) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747821050056
Faculty Opinions recommendation of GLUT4 mobilization supports energetic demands of active synapses.
Chapman, E. R., & Vevea, J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727228790.793544965
Stieger, B. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733253300.793546527
Schmidl, S., Ursu, O., Iancu, C. V., Oreb, M., Oprea, T. I., & Choe, J. (2021) · Research Square · doi:10.21203/rs.3.rs-489875/v1
Vandenberg, R. J., & Mostyn, S. N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734171078.793557574
Membrane Transport: Energetics and Overview
Henderson, P. J. F. (2018) · Springer eBooks · doi:10.1007/978-3-642-35943-9_809-1
Glucose transporter type I deficiency and other glucose flux disorders
Pascual, J. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00062-3 · Cited by 1
Targeting T-cell immunometabolism during transplantationPreprint
Kazmi, S., Khan, M. A., Shamma, T., Altuhami, A., Assiri, A. M., & Broering, D. (2020) · Authorea · doi:10.22541/au.160407370.05004270/v1
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-34126-4.00009-8
Le transporteur de glucose GLUT1 se dévoile
F.A. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70847-8
Defries, D. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101958
Defries, D. M. (2017) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101958-1
Ravindran, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210772119
“decipher the structure of GLUT3 based on the GLUT1 structure (5, 6).”
BackgroundEndosomal GLUT3 is essential for alternative macrophage signaling, polarization, and functionPreprint
Yu, D.-M., Zhao, J., Lee, E. E., Rose, E. K., Mahapatra, R., Choe, J., Abel, E. D., & Wang, R. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.09.515804
“First, after identifying missense mutations that blocked glucose transport in the GLUT1 transporter without impacting protein stability, the orthologous missense mutations were generated in GLUT3 alleles (Deng et al. , 2014; Raja and Kinne, 2020).”
BackgroundMitrovic, D., McComas, S. E., Alleva, C., Bonaccorsi, M., Drew, D., & Delemotte, L. (2023) · eLife · doi:10.7554/elife.84805.sa2
Chen, D., Jiang, H., Yang, B., Guo, B., Li, D., Ye, G., Zhu, Y., Tang, D., & Long, F. (2023) · Authorea · doi:10.22541/au.169420335.53279261/v1
Convex Hull Principle and Distinguishing Proteins from Arbitrary Amino Acid Sequences
Yau, S. S. ‐., Zhao, X. T., Tian, K., & Yu, H. (2023) · Interdisciplinary applied mathematics · doi:10.1007/978-3-031-48295-3_7
Rôle de l'interaction entre PIEZO1 et KCNN4 dans la pathophysiologie érythrocytaire
Allegrini, B. (2023) · theses.fr (ABES) · doi:10.70675/c03a3a6fz2ad3z4fa7zb76az3ef237dbeb44 · Cited by 1
Resistance and toxicity mechanisms of 2-deoxyglucose, a metabolic inhibitor
Laussel, C. (2021) · theses.fr (ABES) · doi:10.70675/0916b559zc9a4z4a61z8b44z95d13e382cb5
Janaszkiewicz, A. (2022) · theses.fr (ABES) · doi:10.70675/24b74a74zebdez43bdz8f63zf05d45174a78
Effets de l’acidose métabolique sur les troubles de l’homéostasie du glucose
Zaïbi, N. (2023) · theses.fr (ABES) · doi:10.70675/1995a59bz68bcz49a3z9e8cza34b9cb43135
Molecular mechanisms of placental pathophysiology
Apicella, C. (2021) · theses.fr (ABES) · doi:10.70675/a60ab099zaef4z4bd2z9b62z58cec0501f95
Carraro, C. B. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-11042024-114616
Hyaluronan and Glucose Dual-targeting Probe: Synthesis and Application
Zhang, H., Chen, C., Han, J., Wang, S., Jia, Q., Ling, P., Li, S., & Fang, J. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107816
Glucose transporter type I deficiency and other glucose flux disorders
Pascual, J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00022-4
LncRNA: Secret Regulators of Cancer Metabolism
Demirkaya, D. B., & Yalçın, S. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_470
Debbiche, R. (2024) · theses.fr (ABES) · doi:10.70675/f312b511za98dz47e2z80c8z6500b5c29011 · Cited by 1
Lin, Z., He, Z., Guo, J., Ji, X., Hu, Z. B., Tang, Y., Wei, C., Liu, J., Wu, W., Ma, J., et al. (2025) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2025.05.007
Glucose and methylglucose transport in human red blood cells and ghosts
Brahm, J. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00057.2024
Spatial mapping of cell-surface protein glycosylation at molecular resolutionPreprint
Joseph, D. M., Sison, N. L., Yurekli, N., Culpepper, S., & Möckl, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.30.679542
Ganguly, M., Maitra, H., Roychowdhury, A., & Hazra, D. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3628948
Kim, J.-H. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1702400
Shriwas, P., Roberts, D. A., Li, Y., Wang, L., Qian, Y., Bergmeier, S. C., Hines, J. V., Adhicary, S., Nielsen, C. M., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.14329567
Shriwas, P., Roberts, D. A., Li, Y., Wang, L., Qian, Y., Bergmeier, S. C., Hines, J. V., Adhicary, S., Nielsen, C. M., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.14329570
Wang, X., Li, Y., Jia, F., Cui, X., Pan, Z., & Wu, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19759550
Dong, Z., Zhang, M.-Y., Qu, L.-X., Zou, J., Yang, Y.-H., Ma, Y.-L., Yang, C.-C., Cao, X.-L., Wang, L.-Y., Zhang, X.-L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981819
Griesshammer, E. (2025) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.76997
Xia, J., Zhang, S., Zhang, R., Wang, A., Zhu, Y., Dong, M., Ma, S., Hong, C., Liu, S., Wang, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21130001
Dong, Z., Zhang, M.-Y., Qu, L.-X., Zou, J., Yang, Y.-H., Ma, Y.-L., Yang, C.-C., Cao, X.-L., Wang, L.-Y., Zhang, X.-L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981822
Wang, X., Li, Y., Jia, F., Cui, X., Pan, Z., & Wu, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19759547
Luo, X., Yang, Z., Chen, J., Shen, M., Wang, K., & Du, Q. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100497 · Cited by 3
Class III facilitative glucose transporters: Beyond glucose transport in health and disease
Lacombe, V. A., Campolo, A. R., Rochowski, M. T., & Beets, C. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153676
Mehta, Y., & Al-Ahmad, A. J. (2026) · Cell and Tissue Research · doi:10.1007/s00441-026-04061-w
Cairey-Remonnay, A. (2014) · theses.fr (ABES) · doi:10.70675/f20f55cdzf783z4c7ez9be1z9f3c07459f41
“Il s’agit de la structure de GLUT1 (Deng et al., 2014), un des premiers transporteurs du glucose identifiés chez l’homme (Mueckler and Thorens, 2013).”
BackgroundInfluentialSchistosoma mansoni sirtuins : characterization of their role in schistosome energy metabolism
Cabezas‐Cruz, A. (2016) · theses.fr (ABES) · doi:10.70675/63e36f10zd08cz4a8aza252z837051c77092
Seiça, A. F. S. (2019) · theses.fr (ABES) · doi:10.70675/8b36cc71ze122z4119z8567z7881644dd48b · Cited by 1
Stage-specific changes in the Krebs cycle network regulate human erythroid differentiation
Romano, M. (2018) · theses.fr (ABES) · doi:10.70675/4312681cz0207z4923zb100z879f8a73681c
Moro, S. (2023) · theses.fr (ABES) · doi:10.70675/448ebcaezb632z4399z9621z6dd72997c343 · Cited by 1
Yang, S., & Song, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.30.721921
Progressive insights into nanomaterials for cancer starvation therapy
Shi, J., Cui, J., Sun, X., Sun, J., He, Z., Luo, C., & Zhang, S. (2026) · Science China Materials · doi:10.1007/s40843-025-3988-6
“(6) Glucose transport inhibitor GLUTs, a crucial transmembrane protein family, regulate the influx of extracellular glucose into cells and act as the pivotal mechanism controlling cellular glucose uptake [116].”
Xiong, T., Yang, X., Li, T., Song, R., Huang, L., Sang, X., Hu, F., Xu, X., & Liu, Z. (2026) · Research · doi:10.34133/research.1315
“Detailed structural analysis of the docking complex revealed an extensive hydrogen-bonding network between FPBA–BSH and key residues within the GLUT1 binding pocket, supporting the hypothesis that GLUT1 may serve as a major mediator of FPBA–BSH cellular uptake [ 30 ].”
Zhao, C., Zhang, B., Chen, J., Li, D., Wu, C., & Zhu, Y. C. (2026) · Advanced Functional Materials · doi:10.1002/adfm.76399
“Glucose transporter protein 1 (Glut1), a membrane-bound transport protein, shows cell type-specific expression levels that are correlated with the capacity of cellular glucose transport and uptake [49].”
Metabolic Marker GLUT1 in Salivary Gland Cancers: Quantification and Effect-Size Estimation
Domka, W., Misiołek, M., Przygórzewska, A., Kubrak, T. P., Myśliwiec, A., Bartusik‐Aebisher, D., & Aebisher, D. (2026) · Biomedicines · doi:10.3390/biomedicines14061300
“GLUT1 is a central mediator of glucose influx and is among the best-characterized facilitative glucose transporters, with a well-defined structure and broad physiological distribution [16,17,34,35].”
Biomimetic Dual-Multivalent Strategy Enabled In Vivo Tumor-Targeted Molecular MRI
Gao, J., Xiao, X., Luo, M., Liu, M., Wang, Y., Bindi, J., Parigi, G., Dai, L., Meade, T. J., & Tang, J. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c01551
Andersson, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30042-4.00017-1
Bueno, J. G. R., Fier, Í., Kell, D. B., & dos Santos, L. V. (2026) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2026.2680416
“Only a few eukaryotic sugar transporters, such as human GLUT1 [138], fungal PiPT [139], and plant nRT1.”
Identification and Inhibition of GLUT like proteins in Trichuris spp as a druggable targetPreprint
Turner, M., Palinski, J., Else, K. J., & Moore, K. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.30.735466
Mapping pathogenic patterns in membrane transporters from the GLUT transporter familyPreprint
Kadášová, N., Martinát, D., Špačková, A., Vařeková, I. H., & Berka, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.28.735151
Dong, J., Zhou, J., Hao, J., Kong, S., Yin, C., Wei, D. M., Wang, F., Ma, J., Fang, J., Zhang, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.738372
Red light-responsive bioorthogonal chemistry enabled on-demand prodrug activation for cancer therapy
Cheng, H., Wang, Y., Zhang, J., Pei, Z., Yan, Q., Cai, Z., Zhang, D., Ma, H., Liu, H., Peng, D., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.07.024
“…hypothesized that a saccharide unit could be engineered into BODIPY-caged dihydrotetrazine to promote tumor-specific cellular uptake, given that malignant cancer cells exhibit overexpressed glucose transporters (Glut) on tumor cell surfaces for a higher glycolytic rate compared to normal cells 54 .”
Glucose Transporter 1 in Health and Disease
Tai, Y., Chen, Z., Zhu, Y. C., & Han, W. (2026) · MedComm · doi:10.1002/mco2.70874
“Mechanistically, GLUT1 operates as a uniporter via an alternating access mechanism, where its conformation cyclically changes to expose a glucose-binding site to the outside and then the inside of the cell, allowing glucose to flow down its concentration gradient [ 1, 49 ].”
Lazzari, S., Giovannetti, A., Petrizzelli, F., Paolis, V. D., Matarazzo, F., Crevenna, Á. H., Biagini, T., Mazza, T., Parisi, C., & Caputo, V. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01584-4
“In silico approaches suggest that variants may destabilize GLUT1 structure or alter protein interactions (Deng et al. 2014; Park 2015; Galochkina et al. 2019; Raja and Kinne 2020).”
Zeng, J., Zhang, J., Schulz, J., Arafah, A. D. B., Lee, S., Yam, M., Shen, Y., Zhou, F., Zhang, T., Gillies, M. C., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14081715
“Notably, SLC2A1/GLUT1 was enriched in macular EVs, and, given the established role of GLUT1 in glucose transport across the RPE and in supporting photoreceptor energy metabolism, its enrichment may reflect the higher metabolic demands of the macular region [33,61].”
Prognostic significance of GLUT-1 in adenoid cystic carcinoma
Özdoğan, A., Kuşçu, O., Pamuk, E., Özoğul, E., & Tezel, G. G. (2026) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-026-10499-z
Καλογιάννη, Γ. (2022) · University of Thessaly Institutional Repository (University of Thessaly)
Pho84/GLUT2 are cellular myo-inositol exporters regulated by inositol pyrophosphates
Su, X. B., Zhang, X., Fedeli, V., Ko, A.-L. A., Fu, J. N., Fiedler, D., & Saiardi, A. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00888-9
“Although the structures of other SLC2A family members, such as GLUT1 (Deng et al, 2014) and GLUT3 (Deng et al, 2015), have been solved, that of GLUT2 has not.”
Decoding plant vacuolar phosphate efflux: Structural and dynamic insights from rice VPE2
Zuo, J., Cao, S., Tang, Y., He, H., Zhang, J., Li, P., Chen, Y., Yin, P., Wang, C., Xiong, L., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2611598123
Ho, S., Lee, W.-J., Syahada, J. H., Fitriana, F., Rokhmad, M. F., Sim, H.-Y., Wu, Z., Wang, B., & Han, J. (2026) · Parasites Hosts and Diseases · doi:10.3347/phd.26060
Ze-ming, Z., Wang, D., Tang, W.-J., Chen, X.-L., Li, H., Li, G., Xiao, R., Xu, L.-H., Si, W.-K., & Chen, Z.-Y. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117854
Molecular design and delivery of extracellular and membrane protein degradation chimeras
Lin, S., Zhou, H., Qiu, J., Dang, Y., Kou, L., Zhu, Z., Xu, Z., Lai, Y., & Yu, H. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115959
Identification and Validation of the Nrf2/Slc2a1 Axis in Alzheimer’s Disease
Luo, Y., Deng, J., Loh, Y., Lu, H., Wang, N., Tang, C., & Zhang, B. (2026) · Genes · doi:10.3390/genes17091081
“The Slc2a1 gene encodes glucose transporter 1 (GLUT1), a key transporter responsible for maintaining cerebral glucose uptake and energy metabolism [27].”
Paterson, A., Kuriakose, K., Elkhateeb, N. M., Woodall, A., Bassett, J., Sharma, R., Jovanović, A., Meyer, J., Oldham, A. J., Barsby, A., et al. (2026) · Orphanet Journal of Rare Diseases · doi:10.21203/rs.3.rs-10327622/v1
Paul, A., Xu, L., & Shukla, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.13.751325
“6,15 Because changes in TM7b geometry simultaneously alter the binding cavity and the accessibility of conformational states, helix cracking provides a potential mechanism connecting binding-pocket plasticity, conformational energetics, and substrate promiscuity.”
Momin, M. S. A., Sarkar, D., De, N., Bhunia, D., & Sannigrahi, A. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.24.751570
Arshad, M. B., Tipu, I., Tariq, A., Fareed, M. I., Ali, M., & Mateen, R. M. (2026) · Riphah Journal of Allied Health Sciences
Kamiyama, H., Onizawa, Y., Kubara, K., Matsumoto, Y., Sagane, K., Gotoda, M., Miyazaki, T., Suzuki, Y., Kotake, Y., Takase, Y., et al. (2026) · ChemBioChem · doi:10.1002/cbic.70556
“For mutations at the N411 position (Figure S11) [19], which is located near the glucose permeation pathway, previous reports have suggested that GLUT1 variants, including N411S, may impair glucose transport [20].”
Molecular mechanism of pH-dependent activation in human equilibrative nucleoside transporter 3
Tran, T., & Lin, J. (2026) · Biophysical Journal · doi:10.1016/j.bpj.2026.10.006
CHORUS: A proteome-scale atlas of membrane protein interaction interfaces predicted from sequencePreprint
Zhao, J., Huang, S., & Sun, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.04.756538
Nagata, Y., Tomisaki, I., Matsukawa, T., Quynh, N. T., Tsubonuma, Y., Sugita, Y., Nawata, A., Kokubu, K., Baba, R., Morimoto, H., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209128
“GLUT1 mediates basal glucose uptake into several tissues to maintain glucose homeostasis [39].”
Fatih, J. M., Wee, L. H., Yan, Z., Xu, M., Wang, C., & Li, Y. (2026) · Separation and Purification Technology · doi:10.1016/j.seppur.2026.140577
BindingDB Entry 50007948: The Druggability of Solute Carriers.
BindingDB (2021) · UC San Diego · doi:10.7270/q26113pd
BindingDB (2016) · UC San Diego · doi:10.7270/q2ks6qb8
Metadata
- Authors
- Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N.
- Affiliations
- Center for Life Sciences (CN)
- Tsinghua University (CN)
- Corresponding author
- Yan, Nieng
- Venue
- Nature
- Published
- 2014-05-18
- Volume
- 510
- Issue
- 7503
- Pages
- 121-125
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987612677
- Cited by
- 777
- References
- 62
- Citations by year
- 2026: 50 · 2025: 64 · 2024: 64 · 2023: 52 · 2022: 72 · 2021: 73 · 2020: 70 · 2019: 59 · 2018: 64 · 2017: 67 · 2016: 57 · 2015: 65 · 2014: 19
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- GLUT1, glucose transporters, crystal structure, major facilitator superfamily, inward-open conformation, GLUT1 deficiency syndrome, disease-associated mutations, alternating access mechanism, XylE, proton-coupled transport, anticancer drug targets
- MeSH terms
- Carbohydrate Metabolism, Inborn Errors, Humans, Ligands, Models, Biological, Models, Molecular, Monosaccharide Transport Proteins, Mutation, Structure-Activity Relationship, Protein Structure, Tertiary, Crystallography, X-Ray, Symporters, Escherichia coli Proteins, Glucose Transporter Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.